Skip to main content
Clinical Trials/NCT02834182
NCT02834182UnknownNot Applicable

Functional Magnetic Resonance Imaging Study: Theory of Mind Deficits in Schizophrenia and Bipolar Disorder

CHU de Reims2 sites in 1 country120 target enrollmentStarted: July 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
120
Locations
2
Primary Endpoint
Hamilton Depression Scale

Study Overview

Brief Summary

Theory of mind (TOM), a main component of social cognition processes, refers to the capacity to infer one's own and other person's mental states. Deficits in social cognition are found in patients with schizophrenia and bipolar disorder. The purpose of this study is to compare the neurofunctional profiles of schizophrenic patients, bipolar patients and healthy participants during the performance of a TOM task. Results may help to understand the neural bases of the impairments in social cognition in schizophrenia and bipolar disorder, which may in turn help to propose potential new psychosocial therapeutic approaches in these disorders.

Detailed Description

Theory of mind (TOM) refer to the cognitive ability to attribute mental states to others, which plays an essential role in social communications and interactions between individuals. In several recent papers, it was shown that TOM is impaired in schizophrenia and bipolar disorder. This impairment strongly affects the quality of life in patients suffering from these disorders. The investigators study aims to explore the neural correlates of TOM in schizophrenic and bipolar patients, in comparison with those of healthy participants. These studies will be conducted on 30 schizophrenic patients, 30 bipolar patients, and 60 healthy participants, matched on age and educational level to each patient group. The investigators expect that the study of combined behavioral (neuropsychological tests) and neuro-anatomical data will allow to understand the pathophysiology of the alteration of social cognition processes in these illnesses.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Men or women aged from 18 to 65 years-old, right-handed, with a diagnosis of bipolar -disorder or schizophrenia, according to the DSM-5 criteria
  • Native French speaker
  • No substantial change in treatment for 2 weeks preceding study enrollment
  • Able to provide informed written and verbal consent
  • Healthy Controls :
  • Men or women aged from 18 to 65 years-old, right-handed
  • Native French speaker
  • Able to provide informed written and verbal consent

Exclusion Criteria

  • A recent alcohol and/or drug abuse or dependence (in the last six months)
  • A significant general medical illness, including neurological disorders or head trauma
  • A sensorial impairment uncorrected (visual and/or hearing)
  • Contraindication to the use of MRI
  • Persons under legal incapacity
  • Persons who are not covered by national health insurance
  • Healthy Controls :
  • Severe chronic psychiatric disorders including Bipolar disorder and schizophrenia
  • Depression diagnostic according to DSM-5
  • A personal or first-degree-relative history of bipolar disorder, schizophrenia or schizoaffective disorder according to DSM-5
  • A recent alcohol and/or drug abuse or dependence (in the last six months)
  • A significant general medical illness, including neurological disorders or head trauma
  • A sensorial impairment uncorrected (visual and/or hearing)
  • Contraindication to the use of MRI
  • People particularly protected by the law
  • Persons who are not covered by national health insurance

Outcomes

Primary Outcomes

Hamilton Depression Scale

Time Frame: Up to 15 days after inclusion

Neuropsychological test : Mini International Neuropsychiatric Interview (M.I.N.I.)

Time Frame: Up to 15 days after inclusion

Young Mania Rating Scale

Time Frame: Up to 15 days after inclusion

Scale for the Assessment for Thought, Language and Communication

Time Frame: Up to 15 days after inclusion

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

fMRI of Theory of Mind in Schizophrenia... | Clinical Trial